Immune evasion by rabies viruses through the maintenance of blood-brain barrier integrity

References

• Abelseth MK. An attenuated rabies vaccine for domestic animals produced in tissue culture. Can Vet J 1964; 5: 279–286
   PubMedGoogle Scholar
• Baer, GM, Bellini, WJ, Fishbein, DB 1990. Rhabdoviruses. In: Virology, 2nd ed. Fields BN. New York: Raven Press, pp 883–930.
   Google Scholar
• Centers for Disease Control and Prevention 1999. Human rabies prevention—United States. Recommendations of the Advisory Committee on immunization practice. MMWR Morb Mortal Wkly Rep, 48, 1–21.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention 2007. Human rabies—Indiana and California, 2006. MMWR Morb Mortal Wkly Rep, 56, 361–365.
   Google Scholar
• Dietzschold B, Morimoto K, Hooper DC, Smith JS, Rupprecht CE, Koprowski H. Genotypic and phenotypic diversity of rabies virus variants involved in human rabies: implications for postexposure prophylaxis. J Hum Virol 2000; 3: 50–57
   PubMedGoogle Scholar
• Dietzschold B, Wiktor TJ, Trojanowski JQ, Macfarlan RI, Wunner WH, Torres-Anjel MJ, Koprowski H. Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro. J Virol 1985; 56: 12–18
   PubMed Web of Science ®Google Scholar
• Dietzschold B, Wunner WH, Wiktor TJ, Lopes AD, Lafon M, Smith CL, Koprowski H. Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc Natl Acad Sci U S A 1983; 80: 70–74
   PubMed Web of Science ®Google Scholar
• Dressen DW 1997. A global review of rabies vaccine for human use. Vaccine, 15, s2–s6.
   Google Scholar
• Fu, ZF 1997. Rabies and rabies research: past present and future. Vaccine, 15, s20–s24.
   PubMed Web of Science ®Google Scholar
• Gremliza L. Casuistic to the rabies problem. Z Tropenmed Parasitol 1953; 4: 382–389
   PubMedGoogle Scholar
• Hanlon CA, Niezgoda M, Rupprecht CE. Post exposure prophylaxis for prevention of rabies in dogs. Am J Vet Res 2002; 63: 1096–1100
   PubMed Web of Science ®Google Scholar
• Hattwick MAW, Weiss TT, Stechschulte CJ, Baer GM, Gregg MB. Recovery from rabies: a case report. Ann Intern Med 1972; 76: 931–942
   PubMed Web of Science ®Google Scholar
• Jackson AC. Recovery from rabies. N Engl J Med 2005; 352: 2549–2550
   PubMed Web of Science ®Google Scholar
• Jackson AC, Fenton MB. Human rabies and bat bites. Lancet 2001; 357: 1714
   Google Scholar
• Jackson AC, Reimer DL, Ludwin SK. Spontaneous recovery from the encephalomyelitis in mice caused by street rabies virus. Neuropathol Appl Neurobiol 1989; 15: 459–475
   Google Scholar
• Kasempimolporn S, Hemachudha T, Khawplod P, Manatsathit S. Human immune response to rabies nucleocapsid and glycoprotein antigens. Clin Exp Immunol 1991; 84: 195–199
   PubMedGoogle Scholar
• Kissi B, Tordo N, Bourhy H. Genetic polymorphism in the rabies virus nucleo-protein gene. Virology 1995; 209: 526–537
   PubMed Web of Science ®Google Scholar
• Marquette C, Van Dam AM, Ceccaldi PE, Weber P, Haour F, Tsiang H. Induction of immunoreactive interleukin-1 beta and tumor necrosis factor-alpha in the brains of rabies virus infected rats. J Neuroimmunol 1996; 68: 45–51
   Google Scholar
• Messenger SL, Smith JS, Orciari LA, Yager PA, Rupprecht CE. Emerging pattern of rabies deaths and increased viral infectivity. Emerg Infect Dis 2003; 9: 151–154
   Google Scholar
• Messenger SL, Smith JS, Rupprecht CE. Emerging epidemiology of bat-associated cryptic cases of rabies in humans in the United States. Clin Infect Dis 2002; 35: 738–747
   PubMed Web of Science ®Google Scholar
• Miller SD, Gerety SJ, Kennedy MK, Peterson JD, Trotter JL, Tuohy VK, Waltenbaugh C, Dal Canto MC, Lipton HL. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination. J Neuroimmunol 1990; 26: 9–23
   PubMed Web of Science ®Google Scholar
• Morimoto K, Hooper DC, Bornhorst A, Corisdeo S, Bette M, Fu ZF, Schäfer MK, Koprowski H, Weihe E, Dietzschold B. Intrinsic responses to Borna disease virus infection of the central nervous system. Proc Natl Acad Sci U S A 1996; 93: 13345–13350
   PubMed Web of Science ®Google Scholar
• Morimoto K, Hooper DC, Spitsin S, Koprowski H, Dietzschold B. Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures. J Virol 1999; 73: 510–518
   PubMed Web of Science ®Google Scholar
• Murphy FA. Rabies pathogenesis. Arch Virol 1977; 54: 279–297
   PubMedGoogle Scholar
• Phares TW, Fabis MJ, Brimer CM, Kean RB, Hooper DC. A peroxynitrite-dependent pathway is responsible for blood-brain barrier permeability changes during a CNS inflammatory response; TNF-( is neither necessary nor sufficient. J Immunol 2007; 178: 7334–7343
   PubMed Web of Science ®Google Scholar
• Phares TW, Kean RB, Mikheeva T, Hooper DC. Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J Immunol 2006; 176: 7666–7675
   PubMed Web of Science ®Google Scholar
• Roy A, Hooper DC. Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier. J Virol 2007; 81(15)7993–7998
   PubMed Web of Science ®Google Scholar
• Roy A, Phares TW, Koprowski H, Hooper DC. Failure to open the blood-brain barrier and deliver immune effectors to the CNS tissues leads to the lethal outcome of Silver-haired bat rabies virus infection. J Virol 2007; 81(3)1110–1118
   PubMed Web of Science ®Google Scholar
• Rupprecht CE, Dietzschold B, Campbell JB, Charlton KM, Koprowski H. Consideration of inactivated rabies vaccines as oral immunogens of wild carnivores. J Wildl Dis 1992; 28: 629–35
   Google Scholar
• Rupprecht CE, Glickman LT, Spencer PA, Wiktor TJ. Epidemiology of rabies virus variants. Differentiation using monoclonal antibodies and discriminant analysis. Am J Epidemiol 1987; 126: 298–309
   Google Scholar
• Scott CA, Rossiter JP, Andrew RD, Jackson AC. Structural abnormalities in neurons are sufficient to explain the clinical disease and fatal outcome in experimental rabies in yellow fluorescent protein-expressing transgenic mice. J Virol 2008; 82: 513–521
   PubMed Web of Science ®Google Scholar
• Smith JS, McClelland CL, Reid FL, Baer GM. Dual role of the immune response in street rabies virus infection of mice. Infect Immun 1982; 35: 213–221
   PubMed Web of Science ®Google Scholar
• Suja MS, Mahadevan A, Sundaram C, Mani J, Sagar BC, Hemachudha T, Wacharapluesadee S, Madhusudana SN, Shankar SK. Rabies encephalitis following fox bite–histological and immunohistochemical evaluation of lesions caused by virus. Clin Neuropathol 2004; 23: 271–276
   Google Scholar
• Takayama-Ito M, Inoue K, Shoji Y, Inoue S, Iijima T, Sakai T, Kurane I, Morimoto K. A highly attenuated rabies virus HEP-Flury strain reverts to virulent by single amino acid substitution to arginine at position 333 in glycoprotein. Virus Res 2006; 119: 208–215
   Google Scholar
• Wang ZW, Sarmento L, Wang Y, Li X, Dhingra V, Tseggai T, Jiang B, Fu ZF. Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system. J Virol 2005; 79: 12554–12565
   PubMed Web of Science ®Google Scholar
• Wiktor TJ, Doherty PC, Koprowski H. Suppression of cell-mediated immunity by street rabies virus. J Exp Med 1977; 145: 1617–1622
   PubMedGoogle Scholar
• Wilde H. Failures of post exposure prophylaxis. Vaccine 2007; 25: 7605–7609
   PubMed Web of Science ®Google Scholar
• Willoughby RE, Tieves KS, Hoffman GM, Ghanayem NS, Amelie-Lefond CM, Schwabe MJ, Chusid MJ, Rupprecht CE. Brief report: survival after treatment of rabies with induction of coma. N Engl J Med 2005; 352: 2508–2514
   PubMed Web of Science ®Google Scholar